The UMC Cancer Center partners with several cooperative groups and pharmaceutical companies to offer our adult and pediatric patients access to clinical trials and a range of treatments.
The UMC Cancer Center and Texas Tech University Health Sciences Center are affiliated with the Southwest Oncology Group (SWOG), Alliance for Clinical Trials in Oncology, Texas Cancer Cell Repository, the cell culture drug testing lab for the National Cancer Institute Pediatric Preclinical Testing Program, the COG Cell Line and Xenograft Repository, the Neuroblastoma Pharmacology Resource Laboratory for COG, and the New Approaches to Neuroblastoma Therapy consortium. We are also members of the South Plains Oncology Consortium and the Children’s Oncology Group (COG), the world’s largest organization for childhood cancer research.
Clinical trials are research studies that test the effectiveness of new treatments. They are designed to answer specific questions about safety, benefits, side effects, prevention and more. Participation in a cancer research study, also known as a clinical trial, may result in benefit from some of the latest techniques and therapeutic advances in cancer treatment.
By participating in a clinical trial, you are also helping to improve knowledge in ways that may help people with cancer live longer and enjoy a better quality of life.